Work

A phase 3 randomized study of ASP-1929 photoimmunotherapy in combination with pembrolizumab versus standard of care in locoregional recurrent head and neck squamous cell carcinoma (HNSCC).

Year: 2025

Type: article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.tps6122

Authors: Anastasios Maniakas, Ann M. Gillenwater, David Cognetti, Matthew John Mifsud, Noman Ashraf, Francisco F. Civantos, Hassan Danesi, Bogdan Veresh, Shiou-Yi Ethan Chen, Haiying Dong, Cristina Larracas, Susanne M. Arnold

Institutions: The University of Texas MD Anderson Cancer Center, Thomas Jefferson University, University of South Florida, Tampa General Hospital, University of Miami, Rakuten (United States), University of Kentucky, Markey Cancer Center

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Rakuten Medical

OpenAlex ID: W4410810959

FWCI: 2.908

Cites:

Cited by: 4

Related to: 10